Statistics for A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America

Total visits

views
A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America 253

Total visits per month

views
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0

File Visits

views
Raje_2018_cost-effectiveness.pdf 426

Top country views

views
United States 196
Germany 10
Sweden 7
Ukraine 6
India 4
Russia 4
Canada 3
China 2
Spain 1
United Kingdom 1
Malaysia 1

Top city views

views
Wilmington 51
Fairfield 38
Houston 11
White Plains 9
Cambridge 7
Jacksonville 7
Kiez 7
Stockholm 7
Kiev 6
San Francisco 5
Ann Arbor 4
Washington 4
Dearborn 3
Gunzenhausen 3
New Delhi 3
Toronto 3
Baltimore 2
Kansas City 2
Miami 2
Ashburn 1
Bartlesville 1
Beijing 1
Black Mountain 1
Brooklyn 1
Costa Mesa 1
Lake Mary 1
Madrid 1
Moscow 1
New York 1
Philadelphia 1
Saint Petersburg 1
Scottsdale 1
Seattle 1
Seremban 1
Sholinganallur 1
West Lafayette 1